Ultragenyx CEO talks the company's path to profitability in developing drugs for rare diseases
0
0
10/01/24
Dans
Amérique du Nord / États-Unis
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins 'Closing Bell Overtime' to talk drug trials and development, its path to profitability and more.
Montre plus
0 commentaires
sort Trier par
